Eton Pharmaceuticals, Inc.
ETON- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001710340
In the last 90 days, Eton Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 5 sales; 164 institutions reported holding it in 13F filings for Q2 2026, worth $722.6M in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Eton Pharmaceuticals, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 50
- +17 vs. Q2 2023
- Shares held
- 6.90M
- +923.4K (+15.5%) vs. Q2 2023
- Total value
- $28.8M
- +$7.91M (+37.9%) vs. Q2 2023
- New holders
- 22
- 10 more added
- Sold out
- 5
- 5 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ETON on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 164 | $722.6M |
| Q1 2026 | 116 | $438.6M |
| Q4 2025 | 104 | $277.5M |
| Q3 2025 | 103 | $394.7M |
| Q2 2025 | 87 | $243.3M |
| Q1 2025 | 86 | $189.7M |
| Q4 2024 | 71 | $181.5M |
| Q3 2024 | 48 | $60.0M |
| Q2 2024 | 45 | $28.7M |
| Q1 2024 | 44 | $28.8M |
| Q4 2023 | 56 | $33.5M |
| Q3 2023 | 50 | $28.8M |
| Q2 2023 | 33 | $20.9M |
| Q1 2023 | 35 | $22.5M |
| Q4 2022 | 31 | $18.2M |
| Q3 2022 | 32 | $14.4M |
| Q2 2022 | 29 | $14.6M |
| Q1 2022 | 31 | $27.4M |
| Q4 2021 | 32 | $24.1M |
| Q3 2021 | 37 | $29.5M |
| Q2 2021 | 46 | $48.1M |
| Q1 2021 | 50 | $63.7M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Eton Pharmaceuticals, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Opaleye Management Inc. | 2,430,270 | $10.1M | 3.33% | +145,270+6.4% | Added |
| Vanguard Group Inc | 976,436 | $4.07M | 0.00% | 00.0% | Unchanged |
| Westside Investment Management, Inc. | 528,310 | $2.20M | 0.63% | +9,059+1.7% | Added |
| Paradigm Capital Management Inc | 300,000 | $1.25M | 0.07% | 00.0% | Unchanged |
| BlackRock Inc. | 285,176 | $1.19M | 0.00% | −13,049−4.4% | Reduced |
| Bridgeway Capital Management, LLC | 271,462 | $1.13M | 0.03% | +30,000+12.4% | Added |
| EAM Investors, LLC | 256,623 | $1.07M | 0.21% | +256,623 | New |
| Acuitas Investments, LLC | 219,000 | $913.2K | 0.54% | −291,054−57.1% | Reduced |
| Geode Capital Management, LLC | 217,629 | $907.8K | 0.00% | +7,537+3.6% | Added |
| Ameriprise Financial Inc | 186,562 | $778.0K | 0.00% | +186,562 | New |
| Parkman Healthcare Partners LLC | 165,000 | $688.0K | 0.13% | +165,000 | New |
| Essex Investment Management Co LLC | 110,016 | $458.8K | 0.07% | +43,095+64.4% | Added |
| Acadian Asset Management LLC | 97,264 | $403.0K | 0.00% | +97,264 | New |
| State Street Corp | 81,403 | $339.5K | 0.00% | +10,400+14.6% | Added |
| Millennium Management LLC | 80,320 | $334.9K | 0.00% | +80,320 | New |
| Two Sigma Investments, LP | 79,552 | $331.7K | 0.00% | +79,552 | New |
| Bank of New York Mellon Corp | 79,402 | $331.1K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 65,210 | $271.9K | 0.00% | +65,210 | New |
| Squarepoint Ops LLC | 44,642 | $186.2K | 0.00% | +30,609+218.1% | Added |
| Schonfeld Strategic Advisors LLC | 43,600 | $181.8K | 0.00% | +43,600 | New |
| Renaissance Technologies LLC | 43,200 | $180.0K | 0.00% | +15,600+56.5% | Added |
| Connor, Clark & Lunn Investment Management Ltd. | 38,305 | $159.7K | 0.00% | +38,305 | New |
| Northern Trust Corp | 37,507 | $156.4K | 0.00% | +4,564+13.9% | Added |
| Blair William & Co | 36,979 | $154.2K | 0.00% | 00.0% | Unchanged |
| Hillsdale Investment Management Inc. | 28,800 | $120.1K | 0.01% | +28,800 | New |
| Stratos Wealth Partners, LTD. | 26,878 | $112.1K | 0.00% | −31,147−53.7% | Reduced |
| Goldman Sachs Group Inc | 25,650 | $107.0K | 0.00% | +25,650 | New |
| Jump Financial, LLC | 21,100 | $88.0K | 0.00% | +21,100 | New |
| Chicago Trust Co NA | 16,700 | $69.6K | 0.02% | 00.0% | Unchanged |
| Cubist Systematic Strategies, LLC | 14,672 | $61.2K | 0.00% | +14,672 | New |
| Charles Schwab Investment Management Inc | 13,239 | $55.2K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 11,914 | $49.7K | 0.01% | +11,914 | New |
| Two Sigma Securities, LLC | 11,523 | $48.1K | 0.00% | +11,523 | New |
| Quantum Private Wealth, LLC | 11,500 | $48.0K | 0.02% | 00.0% | Unchanged |
| Heron Bay Capital Management | 11,030 | $46.0K | 0.01% | +11,030 | New |
| Financial Advisors Network, Inc. | 10,633 | $44.3K | 0.01% | +10,633 | New |
| Raymond James & Associates | 10,000 | $41.7K | 0.00% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 4,757 | $19.8K | 0.00% | +4,757 | New |
| Truvestments Capital LLC | 1,848 | $7.71K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,172 | $4.89K | 0.00% | −3,202−73.2% | Reduced |
| Plante Moran Financial Advisors, LLC | 1,000 | $4.17K | 0.00% | 00.0% | Unchanged |
| NewSquare Capital LLC | 1,000 | $4.17K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 922 | $3.85K | 0.00% | +922 | New |
| US Bancorp | 805 | $3.36K | 0.00% | +805 | New |
| BNP Paribas Arbitrage, SA | 350 | $1.46K | 0.00% | 00.0% | Unchanged |
| GWM Advisors LLC | 175 | $730 | 0.00% | +175 | New |
| Wells Fargo & Company | 163 | $680 | 0.00% | +11+7.2% | Added |
| Morgan Stanley | 96 | $400 | 0.00% | −748−88.6% | Reduced |
| Lindbrook Capital, LLC | 4 | $17 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 1 | $4 | 0.00% | +1 | New |
| AWM Investment Company, Inc. | 0 | $0 | 0.00% | −158,676−100.0% | Sold out |
| Bailard, Inc. | 0 | $0 | 0.00% | −12,700−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −5,911−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −5,822−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −4,881−100.0% | Sold out |